BP
CME icon

Ballentine Partners’s CME Group CME Stock Holding History

Ballentine Partners’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35M Sell
6,119
-633
-9% -$175K 0.02% 306
2026
Q1 		$1.99M Buy
6,752
+20
+0.3% +$5.94K 0.03% 203
2025
Q4 		$1.84M Buy
6,732
+267
+4% +$72.6K 0.03% 203
2025
Q3 		$1.75M Buy
6,465
+18
+0.3% +$4.9K 0.02% 218
2025
Q2 		$1.78M Buy
6,447
+619
+11% +$168K 0.03% 214
2025
Q1 		$1.55M Buy
5,828
+45
+0.8% +$11.1K 0.03% 218
2024
Q4 		$1.34M Buy
5,783
+367
+7% +$84.4K 0.02% 236
2024
Q3 		$1.2M Buy
5,416
+351
+7% +$72.6K 0.02% 249
2024
Q2 		$996K Sell
5,065
-189
-4% -$39K 0.02% 262
2024
Q1 		$1.13M Buy
5,254
+60
+1% +$12.6K 0.02% 219
2023
Q4 		$1.09M Buy
5,194
+121
+2% +$25.8K 0.02% 219
2023
Q3 		$1.02M Buy
5,073
+159
+3% +$31.6K 0.02% 199
2023
Q2 		$911K Sell
4,914
-23
-0.5% -$4.25K 0.02% 208
2023
Q1 		$946K Buy
4,937
+741
+18% +$134K 0.02% 199
2022
Q4 		$706K Buy
4,196
+162
+4% +$28.2K 0.02% 227
2022
Q3 		$714K Buy
4,034
+521
+15% +$103K 0.02% 192
2022
Q2 		$719K Buy
3,513
+176
+5% +$37.3K 0.03% 188
2022
Q1 		$793K Buy
3,337
+143
+4% +$33.6K 0.02% 198
2021
Q4 		$730K Hold
3,194
– – 0.02% 218
2021
Q3 		$617K Sell
3,194
-29
-0.9% -$5.88K 0.02% 210
2021
Q2 		$686K Buy
3,223
+14
+0.4% +$2.96K 0.02% 194
2021
Q1 		$655K Buy
3,209
+114
+4% +$22.5K 0.02% 192
2020
Q4 		$563K Sell
3,095
-564
-15% -$95.9K 0.02% 204
2020
Q3 		$612K Sell
3,659
-3,127
-46% -$527K 0.03% 186
2020
Q2 		$1.1M Buy
6,786
+4,091
+152% +$733K 0.05% 132
2020
Q1 		$466K Buy
2,695
+987
+58% +$196K 0.03% 194
2019
Q4 		$343K Buy
1,708
+86
+5% +$17.6K 0.02% 283
2019
Q3 		$343K Buy
1,622
+12
+0.7% +$2.51K 0.02% 263
2019
Q2 		$313K Buy
+1,610
New +$297K 0.02% 282
2019
Q1 		– Sell
-1,169
Closed -$220K – 335
2018
Q4 		$220K Buy
+1,169
New +$216K 0.01% 290

Other funds holding CME

PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SI
Scharf Investments Los Gatos, California $3.03B AUM 7.75% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Ballentine Partners's CME Position: Q2 2026 in Review

Ballentine Partners reduced its CME Group (CME) stake by 9.4% in Q2 2026, selling an estimated $175K and leaving 6,119 shares worth $1.35M. The position accounts for 0.02% of the portfolio, ranked #306.

Ballentine Partners first reported a position in CME in Q4 2018 and has held it in 30 quarters since. The position peaked at $1.99M in Q1 2026. 222 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Ballentine Partners held 6,119 shares of CME Group worth $1.35M as of Q2 2026.
  • Ballentine Partners sold 633 CME Group shares in Q2 2026, an estimated $175K.
  • CME Group made up 0.02% of Ballentine Partners's portfolio in Q2 2026, its #306 holding.
  • Ballentine Partners first reported a position in CME Group in Q4 2018 and has held it in 30 quarters since.
  • Ballentine Partners's CME Group position peaked at $1.99M in Q1 2026.
  • 222 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.